• Age group most affected: Teenagers and young adults (15‑30 years), although it can occur at any age.
• Gender: Slight male predominance (≈55 % male).
• Prevalence: In the United States, peritonsillar abscess accounts for about 30 % of all deep head‑and‑neck infections, with an estimated incidence of 30–45 per 100,000 persons per year【1】.
• Geography: More common in temperate climates where streptococcal throat infections are frequent.

The condition is considered a medical emergency when airway obstruction threatens breathing, but most cases can be treated effectively with antibiotics and a simple outpatient procedure.

Symptoms

Symptoms develop rapidly—often within 48 hours after a bout of sore throat— and may include:

• Severe unilateral throat pain: Usually worse on one side, radiating to the ear.
• Fever & chills: Body temperature often exceeds 38 °C (100.4 °F).
• Difficulty opening the mouth (trismus): Due to inflammation of the pterygoid muscles.
• “Hot potato” voice: Muffled, nasal quality caused by swelling.
• Swollen, erythematous tonsil: The affected tonsil appears pushed forward and reddened.
• Uvula deviation: The uvula is displaced away from the affected side.
• Ear pain: Referral pain via the glossopharyngeal nerve.
• Drooling or inability to swallow liquids: Fear of pain leads to decreased oral intake.
• Neck stiffness or palpable bulge: A soft, fluctuant mass may be felt deep to the tonsil.
• General malaise, fatigue, loss of appetite.

Not all patients have every symptom; children often present with less specific signs such as irritability and refusal to eat.

Causes and Risk Factors

Primary cause

Quinsy usually follows an acute bacterial tonsillitis—most often caused by Streptococcus pyogenes (group A strep) or mixed aerobic‑anaerobic flora (including Staphylococcus aureus, Fusobacterium spp.). The infection spreads from the tonsillar crypts into the peritonsillar space, leading to cellulitis and, eventually, pus formation.

Risk factors

• Recent or untreated tonsillitis: Inadequate antibiotic therapy increases risk.
• Age 15‑30 years: Peak incidence coincides with high social interaction and viral upper‑respiratory infections.
• Smoking & alcohol use: Irritate mucosal surfaces and impair local immunity.
• Immunocompromise: HIV, diabetes, chemotherapy, or chronic steroid use.
• Poor oral hygiene & dental disease: Provides a reservoir for anaerobic bacteria.
• Previous peritonsillar abscess: Recurrence occurs in 10‑20 % of cases.
• Large tonsils (grade III–IV): Anatomical crowding predisposes to obstruction and infection.

Diagnosis

Because the condition can progress quickly, a prompt clinical assessment is essential.

History and Physical Examination

• Focused history of recent sore throat, fever, and unilateral symptoms.
• Inspection of the oropharynx for tonsillar swelling, uvula deviation, and pus.
• Palpation of the peritonsillar area to detect tenderness, fluctuation, and “bulging” of the soft palate.
• Assessment of airway patency—listen for stridor or signs of respiratory distress.

Imaging (when needed)

• Contrast‑enhanced CT scan of the neck: Gold standard for delineating an abscess, especially if deep neck space involvement is suspected.
• Ultrasound (in-office): Useful for distinguishing cellulitis (diffuse swelling) from abscess (fluid collection) and for guiding needle aspiration.

Laboratory Tests

• Complete blood count – typically shows leukocytosis with neutrophil predominance.
• CRP & ESR – elevated, reflecting acute inflammation.
• Throat culture or rapid strep test – not always performed because treatment is empirical, but can guide antibiotic choice if performed.
• Blood cultures – reserved for patients with systemic signs of sepsis.

Treatment Options

Management combines antimicrobial therapy, drainage of pus, and supportive care.

Antibiotics

Empiric broad‑spectrum coverage is started immediately, then tailored if cultures are available.

• First‑line oral regimen: Amoxicillin‑clavulanate 875 mg/125 mg twice daily for 10 days.
• Penicillin‑allergic patients: Clindamycin 300 mg four times daily or a macrolide (azithromycin 500 mg daily) plus metronidazole 500 mg three times daily.
• IV therapy (hospitalized or severe cases): Ampicillin‑sulbactam 3 g IV q6h or ceftriaxone 2 g IV daily plus metronidazole 500 mg IV q8h.

Duration: 10–14 days; a shorter course (5 days) may be sufficient after adequate drainage, according to recent NICE guidelines.

Drainage Procedures

1. Aspiration: Needle aspiration with a 20‑gauge needle under local anesthesia; aspiration of pus confirms diagnosis and reduces pressure.
<
2. Incision & drainage (I&D): Performed in the office or emergency department; a small horizontal incision in the peritonsillar space releases pus.
3. Quinsy tonsillectomy: Immediate tonsil removal during the same encounter; reserved for recurrent abscesses or when I&D fails.

Supportive Care

• Hydration – encourage fluids; consider IV fluids if oral intake is poor.
• Analgesia – acetaminophen or ibuprofen for pain and fever.
• Salt‑water gargles (warm saline) 3–4 times daily to soothe the throat.
• Rest and avoid irritants (smoke, spicy foods).

Living with Quinsy (Peritonsillar Cellulitis)

Day‑to‑day management

• Follow medication schedule: Finish the full antibiotic course even if symptoms improve.
• Monitor swelling and pain: Keep a daily log; worsening pain or new fever warrants prompt reevaluation.
• Soft‑diet: Yogurt, applesauce, smoothies, and broth reduce throat irritation.
• Oral hygiene: Gentle brushing and alcohol‑free mouthwash to reduce bacterial load.
• Voice rest: Speak minimally to avoid strain.
• Follow‑up appointments: Usually within 48 hours after drainage to ensure resolution.

When to Return to Work/School

Most patients can resume normal activities once afebrile, pain‑controlled with oral analgesics, and able to swallow soft foods—typically 3–5 days after drainage and antibiotics.

Prevention

• Prompt treatment of sore throats: Seek medical care for fever, severe pain, or worsening symptoms.
• Complete prescribed antibiotics: Never stop early, even if you feel better.
• Maintain good oral hygiene: Brush twice daily, floss, and replace missing teeth.
• Quit smoking & limit alcohol: Reduces mucosal irritation.
• Vaccinations: Annual influenza vaccine and updated COVID‑19 boosters lower the risk of secondary bacterial infections.
• Consider tonsillectomy: For individuals with ≥3 documented peritonsillar abscesses or chronic recurrent tonsillitis, elective tonsil removal reduces recurrence by up to 85 % (Cochrane review, 2020).

Complications

If untreated or inadequately drained, quinsy can spread to deeper neck spaces, leading to serious sequelae:

• Airway obstruction: Rapid swelling can cause respiratory distress, a life‑threatening emergency.
• Ludwig’s angina: Necrotizing cellulitis of the submandibular space.
• Parapharyngeal & retropharyngeal abscess: May require surgical drainage and can affect spinal structures.
• Sepsis: Systemic infection with fever, hypotension, organ dysfunction.
• Scar tissue & chronic dysphagia: Repeated infections can lead to fibrosis around the tonsil.
• Spread to the mediastinum: Extremely rare but documented in severe cases.

When to Seek Emergency Care

**Sources**

1. Centers for Disease Control and Prevention. “Peritonsillar Abscess.” CDC, 2022.
2. Mayo Clinic. “Peritonsillar Abscess (Quinsy).” Mayo Clinic, 2023.
3. World Health Organization. “Burden of Acute Respiratory Infections.” WHO, 2021.
4. National Institute of Allergy and Infectious Diseases. “Streptococcal Pharyngitis.” NIH, 2022.
5. Cochrane Database of Systematic Reviews. “Tonsillectomy for recurrent peritonsillar abscess.” 2020.
6. American Academy of Otolaryngology–Head and Neck Surgery. Clinical practice guideline: “Management of Peritonsillar Abscess.” 2021.